Crohn's Disease Clinical Trials near Pittsburgh, PA
14 studies for Crohn's Disease are recruiting at 15 sites within 50 miles of Pittsburgh, Pennsylvania, according to ClinicalTrials.gov data processed .
Distances are city-level approximations. See all Crohn's Disease trials in the US or all trials near Pittsburgh.
Recruiting now
Crohn's Disease studies enrolling near Pittsburgh
- Autologous Stem Cell Transplantation for Crohn's Disease
NCT00692939
- Phase 1/2
- Ages 10 to 60 years
- Sex: All
Nearest sites: Children's Hospital of Pittsburgh of UPMC-Bone Marrow Team (Pittsburgh, PA); UPMC Prebyterian- Adult Gastroenterology (Pittsburgh, PA)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 2 sites within 50 mi
- Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT
NCT01962415
- Phase 2
- Ages 2 months to 55 years
- Sex: All
Nearest site: UPMC Children's Hospital of Pittsburgh (Pittsburgh, PA)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
NCT03816345
- Phase 1
- Ages 18 years and older
- Sex: All
Nearest site: UPMC Hillman Cancer Center (Pittsburgh, PA)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Inflammatory Bowel Disease (IBD) Research Registry
NCT04243525
- Observational
- Ages 18 years and older
- Sex: All
Nearest site: University of Pittsburgh Medical Center (Pittsburgh, PA)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Data Collection Study of Patients With Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT With RIC
NCT04528355
- Observational
- Ages 2 months to 60 years
- Sex: All
Nearest site: UPMC Children's Hospital of Pittsburgh (Pittsburgh, PA)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease
NCT05781152
- Phase 4
- Ages 6 to 17 years
- Sex: All
Nearest site: UPMC Children's Hospital of Pittsburgh (Pittsburgh, PA)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
NCT07184931
- Phase 3
- Ages 16 to 80 years
- Sex: All
Nearest site: The Allegheny Health Network (AHN) Center for Digestive Health-Site Number: 8400107 (Pittsburgh, PA)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
NCT07184944
- Phase 3
- Ages 16 to 80 years
- Sex: All
Nearest site: The Allegheny Health Network (AHN) Center for Digestive Health-Site Number: 8400107 (Pittsburgh, PA)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- COMPARE - Pediatric Inflammatory Bowel Disease (PIBD)
NCT07198113
- Observational
- Ages 1 year to 18 years
- Sex: All
Nearest site: University of Pittsburgh Medical Center, Children's Hospital (Pittsburgh, PA)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
NCT06045754
- Phase 4
- Ages 18 to 70 years
- Sex: All
Nearest site: Allegheny Health Network (Wexford, PA)
- Distance to nearest recruiting site
- ~13 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
NCT06430801
- Phase 3
- Ages 16 to 80 years
- Sex: All
Nearest site: Frontier Clinical Research, LLC ( Site 5098) (Uniontown, PA)
- Distance to nearest recruiting site
- ~40 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease
NCT06456593
- Phase 2
- Ages 18 to 75 years
- Sex: All
Nearest site: Frontier Clinical Research, LLC (Uniontown, PA)
- Distance to nearest recruiting site
- ~40 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
NCT06819878
- Phase 3
- Ages 16 to 80 years
- Sex: All
Nearest site: Frontier Clinical Re search, LLC (Uniontown, PA)
- Distance to nearest recruiting site
- ~40 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
NCT07499232
- Phase 3
- Ages 18 years and older
- Sex: All
Nearest site: Frontier Clinical Research (Uniontown, PA)
- Distance to nearest recruiting site
- ~40 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
FAQ
Common questions
What is a clinical trial?
Is there compensation for joining a Crohn's Disease clinical trial?
How do I check if I'm eligible?
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.